Literature DB >> 19948884

Cell cycle arrest by transforming growth factor beta1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction.

Piyali Mukherjee1, Sherry L Winter, Mark G Alexandrow.   

Abstract

Understanding inhibitory mechanisms of transforming growth factor beta1 (TGF-beta1) has provided insight into cell cycle regulation and how TGF-beta1 sensitivity is lost during tumorigenesis. We show here that TGF-beta1 utilizes a previously unknown mechanism targeting the function of prereplication complexes (pre-RCs) to acutely block S-phase entry when added to cells in late G(1), after most G(1) events have occurred. TGF-beta1 treatment in early G(1) suppresses Myc and CycE-Cdk2 and blocks pre-RC assembly. However, TGF-beta1 treatment in late G(1) acutely blocks S-phase entry by inhibiting activation of fully assembled pre-RCs, with arrest occurring prior to the helicase unwinding step at G(1)/S. This acute block by TGF-beta1 requires the function of Rb in late G(1) but does not involve Myc/CycE-Cdk2 suppression or transcriptional control. Instead, Rb mediates TGF-beta1 late-G(1) arrest by targeting the MCM helicase. Rb binds the MCM complex during late G(1) via a direct interaction with Mcm7, and TGF-beta1 blocks their dissociation at G(1)/S. Loss of Rb or overexpression of Mcm7 or its Rb-binding domain alone abrogates late-G(1) arrest by TGF-beta1. These results demonstrate that TGF-beta1 acutely blocks entry into S phase by inhibiting pre-RC activation and suggest a novel role for Rb in mediating this effect of TGF-beta1 through direct interaction with and control of the MCM helicase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948884      PMCID: PMC2812244          DOI: 10.1128/MCB.01152-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins.

Authors:  A Nishihara; J Hanai; T Imamura; K Miyazono; M Kawabata
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

2.  CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis.

Authors:  Niels Mailand; John F X Diffley
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast.

Authors:  Philip Zegerman; John F X Diffley
Journal:  Nature       Date:  2006-12-13       Impact factor: 49.962

4.  MCM7 amplification and overexpression are associated with prostate cancer progression.

Authors:  B Ren; G Yu; G C Tseng; K Cieply; T Gavel; J Nelson; G Michalopoulos; Y P Yu; J-H Luo
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

5.  Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors.

Authors:  Sharon E Reed; Elizabeth M Staley; John P Mayginnes; David J Pintel; Gregory E Tullis
Journal:  J Virol Methods       Date:  2006-09-06       Impact factor: 2.014

6.  Regulation of replication fork progression through histone supply and demand.

Authors:  Anja Groth; Armelle Corpet; Adam J L Cook; Daniele Roche; Jiri Bartek; Jiri Lukas; Geneviève Almouzni
Journal:  Science       Date:  2007-12-21       Impact factor: 47.728

7.  Non-transcriptional control of DNA replication by c-Myc.

Authors:  David Dominguez-Sola; Carol Y Ying; Carla Grandori; Luca Ruggiero; Brenden Chen; Muyang Li; Denise A Galloway; Wei Gu; Jean Gautier; Riccardo Dalla-Favera
Journal:  Nature       Date:  2007-06-27       Impact factor: 49.962

8.  Phosphorylation of Mcm2 by Cdc7 promotes pre-replication complex assembly during cell-cycle re-entry.

Authors:  Li-Chiou Chuang; Leonardo K Teixeira; James A Wohlschlegel; Martha Henze; John R Yates; Juan Méndez; Steven I Reed
Journal:  Mol Cell       Date:  2009-07-31       Impact factor: 17.970

9.  Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.

Authors:  K A Honeycutt; Z Chen; M I Koster; M Miers; J Nuchtern; J Hicks; D R Roop; J M Shohet
Journal:  Oncogene       Date:  2006-03-06       Impact factor: 9.867

10.  Mammalian MCM loading in late-G(1) coincides with Rb hyperphosphorylation and the transition to post-transcriptional control of progression into S-phase.

Authors:  Piyali Mukherjee; Thinh V Cao; Sherry L Winter; Mark G Alexandrow
Journal:  PLoS One       Date:  2009-05-07       Impact factor: 3.240

View more
  33 in total

Review 1.  Control of DNA replication by cyclin-dependent kinases in development.

Authors:  Daniel Fisher
Journal:  Results Probl Cell Differ       Date:  2011

2.  High mobility group protein-mediated transcription requires DNA damage marker γ-H2AX.

Authors:  Indrabahadur Singh; Nihan Ozturk; Julio Cordero; Aditi Mehta; Diya Hasan; Claudia Cosentino; Carlos Sebastian; Marcus Krüger; Mario Looso; Gianni Carraro; Saverio Bellusci; Werner Seeger; Thomas Braun; Raul Mostoslavsky; Guillermo Barreto
Journal:  Cell Res       Date:  2015-06-05       Impact factor: 25.617

Review 3.  Cancer Biomarkers for Integrative Oncology.

Authors:  Aniruddha Ganguly; David Frank; Nagi Kumar; Yung-Chi Cheng; Edward Chu
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

4.  The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.

Authors:  Sergiy I Borysov; Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

5.  Oncogenic activity of MCM7 transforming cluster.

Authors:  Jian-Hua Luo
Journal:  World J Clin Oncol       Date:  2011-02-10

6.  Chromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin.

Authors:  Philip G Wong; Michele A Glozak; Thinh V Cao; Cyrus Vaziri; Edward Seto; Mark Alexandrow
Journal:  Cell Cycle       Date:  2010-11-11       Impact factor: 4.534

7.  Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer.

Authors:  Mark G Alexandrow; Lanxi J Song; Soner Altiok; Jhanelle Gray; Eric B Haura; Nagi B Kumar
Journal:  Eur J Cancer Prev       Date:  2012-09       Impact factor: 2.497

Review 8.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

9.  TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions.

Authors:  Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

10.  DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.

Authors:  Shuan Shian Huang; Chun-Lin Chen; Franklin W Huang; Wei-Hsien Hou; Jung San Huang
Journal:  J Cell Biochem       Date:  2016-02-18       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.